6-46140216-T-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_014936.5(ENPP4):c.633T>A(p.Asp211Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,612,474 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014936.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENPP4 | NM_014936.5 | c.633T>A | p.Asp211Glu | missense_variant | 2/4 | ENST00000321037.5 | NP_055751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENPP4 | ENST00000321037.5 | c.633T>A | p.Asp211Glu | missense_variant | 2/4 | 1 | NM_014936.5 | ENSP00000318066.3 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151628Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250640Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135440
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460846Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 726736
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151628Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74014
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2024 | The c.633T>A (p.D211E) alteration is located in exon 2 (coding exon 1) of the ENPP4 gene. This alteration results from a T to A substitution at nucleotide position 633, causing the aspartic acid (D) at amino acid position 211 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at